USPTO 2015–2025 USPTO PatentsView US Corporation

PowerVision, Inc.

USPTO PatentsView assignee record - 24 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Powervision ranks #12,628 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 2 technology areas.

#12,628
of 49,997 US assignees by volume
13th percentile
by Innovation Score (23.6/100)
12.5
avg claims per patent
-91%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12628 · US Corporation #12,628 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 24 grants
  • MID-PACK #12,628/49,997
  • PHOTO-FINISH Pentel
  • CPC-NARROW A61F · 2 areas
  • INNOV-THIN 23.6/100
  • CLAIMS-RICH 12.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -91% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pentel Kabushiki Kaisha (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Powervision’s 23.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Powervision

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Powervision's Innovation Score is 23.6/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Powervision?

Each dot is one of Powervision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Powervision’s own 12.5 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Powervision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 0510152025 Granted patents (volume) Avg claims / patent Pentel Kabushiki Kaisha - 24, 3PentelPerceptive Automata, Inc. - 24, 17.29Perceptive Automa…Pison Technology, Inc. - 24, 20.33Pison TechnologyPointr Limited - 24, 19.96PointrPremier Dental Products Company - 24, 18.08Premier Dental Pr…PricewaterhouseCoopers LLP - 24, 20.04Pricewaterhouseco…ProQR Therapeutics II B.V. - 24, 18.5Proqr Therapeutic…Professional Compounding Centers of America - 24, 11.46Professional Comp…PowerVision, Inc. - 24, 12.5Powervision
Powervision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Powervision's grants concentrate

PowerVision, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2016. By volume, Powervision sits between Pentel Kabushiki Kaisha and Professional Compounding Centers of America.

Who files at PowerVision's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows PowerVision holds 24 patents at rank #12,631, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near PowerVision

By rank, the assignees closest to #12,631 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in PowerVision's primary technology class.

Powervision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162017201820192020 2
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
PowerVision, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 16.7%
2016 2 8.3%
2017 3 12.5%
2018 5 20.8%
2019 8 33.3%
2020 2 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

PowerVision, Inc.'s patent record in context - here's where to go next.

  • PowerVision, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #12,628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare PowerVision, Inc. against Pentel Kabushiki Kaisha, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 23.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.